Physician profile
Thao Ngo
NPI 1770515108
$764.27
in general payments reported to CMS, 2019-2025
14 companies · $67.90 in 2025
The $67.90 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.16 · 2020: $15.58 · 2022: $169 · 2023: $257 · 2024: $240 · 2025: $67.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $157.42 | 2022-2024 | Verquvo |
| Novartis Pharmaceuticals Corporation | $115.21 | 2020-2023 | |
| Pfizer INC. | $93.33 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $82.94 | 2022-2025 | Camzyos |
| Sanofi-Aventis U.S. LLC | $48.30 | 2022 | |
| Bridgebio Pharma, INC. | $45.76 | 2025 | Attruby |
| Alnylam Pharmaceuticals INC. | $43.24 | 2023-2024 | Amvuttra |
| Scpharmaceuticals INC. | $42.58 | 2024 | |
| Janssen Pharmaceuticals, INC | $32.74 | 2022 | |
| Medtronic, INC. | $28.55 | 2024 | Mycarelink |
| Amgen INC. | $25.21 | 2024 | Repatha |
| Genzyme Corporation | $21.13 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.16 | 2019 | |
| Heartflow, INC. | $13.70 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thao Ngo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.